Zurich Insurance Group full year 2025 results investor and media presentation/Other important information: Difference between revisions
Appearance
Content deleted Content added
No edit summary Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 307: | Line 307: | ||
<!-- RAG-context: Slide 62 shows the like-for-like growth calculation methodology and specific adjustments for each business KPI: P&C GWP reported USD 46,624m→USD 50,422m, adjusted to 5% l-f-l; P&C insurance revenue reported to 4% l-f-l; Life GWP reported USD 33,061m→USD 36,194m, adjusted to 7% l-f-l; Life long-term PVNBP 14% l-f-l; Life long-term NB CSM 11% l-f-l; Life short-term insurance revenue 9% l-f-l; Life investment contracts fee revenue 13% l-f-l. Adjustments include FX, M&A/other for both FY-24 and FY-25. --> |
<!-- RAG-context: Slide 62 shows the like-for-like growth calculation methodology and specific adjustments for each business KPI: P&C GWP reported USD 46,624m→USD 50,422m, adjusted to 5% l-f-l; P&C insurance revenue reported to 4% l-f-l; Life GWP reported USD 33,061m→USD 36,194m, adjusted to 7% l-f-l; Life long-term PVNBP 14% l-f-l; Life long-term NB CSM 11% l-f-l; Life short-term insurance revenue 9% l-f-l; Life investment contracts fee revenue 13% l-f-l. Adjustments include FX, M&A/other for both FY-24 and FY-25. --> |
||
| ⚫ | |||
<div class="sticky-table-wrapper"> |
|||
| ⚫ | |||
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24 |
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24 |
||
! style="text-align:left |
! style="text-align:left" | Business |
||
! style="text-align:left |
! style="text-align:left" | KPI |
||
! style="text-align: |
! style="text-align:right;width:6em" | FY24 Rep. |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY24 M&A/Other Adj. |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY24 Adj. |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY25 Rep. |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY25 FX |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY25 M&A/Other |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | FY25 Adj. |
||
! style="text-align:right; |
! style="text-align:right;width:6em" | L-f-l (%) |
||
! style="text-align:right; width:6em; white-space:normal;" | L-f-l (%) |
|||
|- |
|- |
||
| style="text-align:left" | P&C |
| style="text-align:left" | P&C |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | GWP |
| style="text-align:left" | GWP |
||
| 46,624 |
| 46,624 |
||
| Line 335: | Line 332: | ||
|- |
|- |
||
| style="text-align:left" | P&C |
| style="text-align:left" | P&C |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Ins. revenue |
| style="text-align:left" | Ins. revenue |
||
| 44,792 |
| 44,792 |
||
| Line 347: | Line 343: | ||
|- |
|- |
||
| style="text-align:left" | Life |
| style="text-align:left" | Life |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | GWP |
| style="text-align:left" | GWP |
||
| 33,061 |
| 33,061 |
||
| Line 359: | Line 354: | ||
|- |
|- |
||
| style="text-align:left" | Life – long term |
| style="text-align:left" | Life – long term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | PVNBP |
| style="text-align:left" | PVNBP |
||
| 16,891 |
| 16,891 |
||
| Line 371: | Line 365: | ||
|- |
|- |
||
| style="text-align:left" | Life – long term |
| style="text-align:left" | Life – long term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | NB CSM |
| style="text-align:left" | NB CSM |
||
| 1,094 |
| 1,094 |
||
| Line 383: | Line 376: | ||
|- |
|- |
||
| style="text-align:left" | Life – short term |
| style="text-align:left" | Life – short term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Ins. revenue |
| style="text-align:left" | Ins. revenue |
||
| 2,804 |
| 2,804 |
||
| Line 395: | Line 387: | ||
|- |
|- |
||
| style="text-align:left" | Life – inv. contracts |
| style="text-align:left" | Life – inv. contracts |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Fee revenue |
| style="text-align:left" | Fee revenue |
||
| 717 |
| 717 |
||
| Line 406: | Line 397: | ||
| 13% |
| 13% |
||
|} |
|} |
||
</div> |
|||
'''Notes:''' |
'''Notes:''' |
||